Biotechnology Assets S.A. (BST) — Capital Reinvestment Ratio
Biotechnology Assets S.A. (BST) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (€658.13K) in capital expenditures (€1.99K). Check Biotechnology Assets S.A. tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Biotechnology Assets S.A. Capital Reinvestment Ratio (2015–2023)
This chart tracks Biotechnology Assets S.A.'s Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Biotechnology Assets S.A. cash flow conversion.
Annual Capital Reinvestment Ratio for Biotechnology Assets S.A. (2015–2023)
Year-by-year Capital Reinvestment Ratio for Biotechnology Assets S.A. from 2015 to 2023. See Biotechnology Assets S.A. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 6.83x | €47.74K | €325.97K | ▲ +15235.3% |
| 2020 | 0.04x | €8.79 Million | €391.53K | ▼ -99.4% |
| 2017 | 7.33x | €213.49K | €1.56 Million | ▲ +508.5% |
| 2016 | 1.20x | €2.71 Million | €3.27 Million | ▼ -82.2% |
| 2015 | 6.75x | €158.16K | €1.07 Million | — |